203 related articles for article (PubMed ID: 33477348)
21. Oral and Subcutaneous Immunization with a Plant-Produced Mouse-Specific Zona Pellucida 3 Peptide Presented on Hepatitis B Core Antigen Virus-like Particles.
Ghasemian K; Broer I; Schön J; Killisch R; Kolp N; Springer A; Huckauf J
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851339
[TBL] [Abstract][Full Text] [Related]
22. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
23. Baculovirus expression of chimeric hepatitis B virus core particles with hepatitis E virus epitopes and their use in a hepatitis E immunoassay.
Touze A; Enogat N; Buisson Y; Coursaget P
J Clin Microbiol; 1999 Feb; 37(2):438-41. PubMed ID: 9889237
[TBL] [Abstract][Full Text] [Related]
24. [Antigenic analysis of two chimeric hepatitis B core particles presenting the preS1 neutralizing epitopes].
Su QD; Guo MZ; Yi Y; Chen SY; Jia ZY; Lu XX; Qiu F; Bi SL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):336-9. PubMed ID: 24645316
[TBL] [Abstract][Full Text] [Related]
25. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
[TBL] [Abstract][Full Text] [Related]
26. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
[TBL] [Abstract][Full Text] [Related]
27. Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.
Rutkowska DA; Mokoena NB; Tsekoa TL; Dibakwane VS; O'Kennedy MM
BMC Vet Res; 2019 Dec; 15(1):432. PubMed ID: 31796116
[TBL] [Abstract][Full Text] [Related]
28. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
29. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
Wei S; Lei Y; Yang J; Wang X; Shu F; Wei X; Lin F; Li B; Cui Y; Zhang H; Wei S
Vaccine; 2018 Apr; 36(17):2273-2281. PubMed ID: 29576303
[TBL] [Abstract][Full Text] [Related]
30. Porcine circovirus type 2 protective epitope densely carried by chimeric papaya ringspot virus-like particles expressed in Escherichia coli as a cost-effective vaccine manufacture alternative.
Aguilera BE; Chávez-Calvillo G; Elizondo-Quiroga D; Jimenez-García MN; Carrillo-Tripp M; Silva-Rosales L; Hernández-Gutiérrez R; Gutiérrez-Ortega A
Biotechnol Appl Biochem; 2017 May; 64(3):406-414. PubMed ID: 26970530
[TBL] [Abstract][Full Text] [Related]
31. Potent neutralization activity against type O foot-and-mouth disease virus elicited by a conserved type O neutralizing epitope displayed on bovine parvovirus virus-like particles.
Chang J; Zhang Y; Yang D; Jiang Z; Wang F; Yu L
J Gen Virol; 2019 Feb; 100(2):187-198. PubMed ID: 30547855
[TBL] [Abstract][Full Text] [Related]
32. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
33. Production of hepatitis E virus-like particles presenting multiple foreign epitopes by co-infection of recombinant baculoviruses.
Shima R; Li TC; Sendai Y; Kataoka C; Mori Y; Abe T; Takeda N; Okamoto T; Matsuura Y
Sci Rep; 2016 Feb; 6():21638. PubMed ID: 26905478
[TBL] [Abstract][Full Text] [Related]
34. Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope.
Sadeyen JR; Tourne S; Shkreli M; Sizaret PY; Coursaget P
Virology; 2003 Apr; 309(1):32-40. PubMed ID: 12726724
[TBL] [Abstract][Full Text] [Related]
35. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
[TBL] [Abstract][Full Text] [Related]
36. Transient Bluetongue virus serotype 8 capsid protein expression in
van Zyl AR; Meyers AE; Rybicki EP
Biotechnol Rep (Amst); 2016 Mar; 9():15-24. PubMed ID: 28352588
[TBL] [Abstract][Full Text] [Related]
37. Epitope Presentation of Dengue Viral Envelope Glycoprotein Domain III on Hepatitis B Core Protein Virus-Like Particles Produced in
Pang EL; Peyret H; Ramirez A; Loh HS; Lai KS; Fang CM; Rosenberg WM; Lomonossoff GP
Front Plant Sci; 2019; 10():455. PubMed ID: 31057572
[TBL] [Abstract][Full Text] [Related]
38. Identification of B-cell epitopes in the capsid protein of avian hepatitis E virus (avian HEV) that are common to human and swine HEVs or unique to avian HEV.
Guo H; Zhou EM; Sun ZF; Meng XJ; Halbur PG
J Gen Virol; 2006 Jan; 87(Pt 1):217-223. PubMed ID: 16361434
[TBL] [Abstract][Full Text] [Related]
39. Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model.
Chu X; Li Y; Long Q; Xia Y; Yao Y; Sun W; Huang W; Yang X; Liu C; Ma Y
Int J Nanomedicine; 2016; 11():2417-29. PubMed ID: 27313455
[TBL] [Abstract][Full Text] [Related]
40. Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface.
Wang D; Zhang S; Zou Y; Yu W; Jiang Y; Zhan Y; Wang N; Dong Y; Yang Y
Front Cell Infect Microbiol; 2018; 8():232. PubMed ID: 30038901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
